Brain Research

Brain Canada’s flagship program awards $2.8 million for brain research

Retrieved on: 
Thursday, September 21, 2023
Hospital for Sick Children, Hospital for Sick Children (Toronto), University, David Azrieli, Brain Research, Ambition Institute, Public, CIHR, Research, Directory, Azrieli Center, Disorder, LOI, Pain, Neuroscience, University of Toronto, Myenteric plexus, Canadian Institutes of Health Research, Brain, Government of Canada, Hospital, Health, Health Canada, Peer review, Injury, Medical device, Health insurance

MONTREAL, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Supported by the Canada Brain Research Fund and anchored by a lead gift from the Azrieli Foundation, the Future Leaders in Canadian Brain Research program aims to accelerate novel and transformative research that will fundamentally change our understanding of nervous system function and dysfunction and their impact on health. In its fourth year, this flagship program is providing funding to its largest-ever cohort of researchers, with 28 recipients—almost 30% more researchers than previous years. Over the course of four years, the Future Leaders in Canadian Brain Research program has granted awards to a total of 88 promising early-career researchers. The program is made possible through a substantial contribution from the Azrieli Foundation, with support this year from The Erika Legacy Foundation, The Arrell Family Foundation, the Segal Foundation, and the Canadian Institutes of Health Research (CIHR).

Key Points: 
  • Over the course of four years, the Future Leaders in Canadian Brain Research program has granted awards to a total of 88 promising early-career researchers.
  • With the support of Brain Canada and its donors and partners, these visionary researchers are making substantial contributions to brain research across the country and around the world.
  • “Brain Canada is the leading foundation dedicated to advancing neuroscience in this country,” says Naomi Azrieli, Brain Canada Chair.
  • To date, Health Canada has invested $200 million through the CBRF which has been matched by Brain Canada Foundation and its donors and partners.

Karl Friston joins VERSES as Chief Scientist to Lead New Era in Artificial Intelligence

Retrieved on: 
Thursday, December 1, 2022
White paper, NEO, Computational neuroscience, Royal, Nature, Neuroimaging, Artificiality, AI, Karl J. Friston, R, Brain, Wellcome Trust Centre for Cell-Matrix Research, Royal Society, Organization for Human Brain Mapping, AGI, Weldon Memorial Prize, University College London, China White Paper, Research, Semantic Scholar, University, Brain Research, Academia Europaea, Brain mapping, Radboud University Nijmegen, Nervous system, Creative Commons, EMBO, Artificial intelligence, Royal Society of Biology, Human, ArXiv, Physics, Franck–Condon principle, Artificial general intelligence, Medical device, Neuroscience

It is with great enthusiasm and excitement that we welcome Karl Friston to VERSES as our Chief Scientist, said Gabriel Ren, Founder, and CEO of VERSES.

Key Points: 
  • It is with great enthusiasm and excitement that we welcome Karl Friston to VERSES as our Chief Scientist, said Gabriel Ren, Founder, and CEO of VERSES.
  • Friston who was ranked #1 most influential neuroscientist in the world by Semantic Scholar in 2016 has had an illustrious and decorated scientific career.
  • I am genuinely delighted to be working alongside Karl Friston at VERSES, said Maxwell Ramstead, Director of Research at VERSES.
  • VERSES is a cognitive computing company specializing in next-generation Artificial Intelligence.

Major $2M investment in next generation of Canadian neuroscientists

Retrieved on: 
Thursday, September 2, 2021
Epilepsy, Ambition Institute, University, Quality of life, Program, University of Manitoba, Diagnosis, Brain, GLOBE, Research, DNA, David Azrieli, Azrieli Sarona Tower, DNA repair, Neurodevelopmental disorder, Therapy, Bipolar disorder, Sherbrooke, Mental health, Â, Partnership, Lists of diseases, Solution, Imagination, Brain Research, CEO, Health Canada, Organization, Rett, Government of Canada, Department, Pharmacology, Multiple sclerosis, Pharmaceutical industry, Management, Medical imaging, Medical device

It is an investment today that is sure to yield breakthrough discoveries for the challenges of tomorrow.

Key Points: 
  • It is an investment today that is sure to yield breakthrough discoveries for the challenges of tomorrow.
  • Brain Canada will launch open funding competitions under this program every year, ultimately supporting 100 early-career researchers.
  • To learn more about this years cohort of Future Leaders in Canadian Brain Research and to read about their projects, visit braincanada.ca/directory-funded-grants .
  • Brain Canada is a national non-profit organization that enables and supports excellent, innovative, paradigm-changing brain research in Canada.